Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
XT-150 by Xalud Therapeutics for Peripheral Neuropathic Pain: Likelihood of Approval
XT-150 is under clinical development by Xalud Therapeutics and currently in Phase II for Peripheral Neuropathic Pain. According to GlobalData,...
Data Insights
XT-150 by Xalud Therapeutics for Osteoarthritis Pain: Likelihood of Approval
XT-150 is under clinical development by Xalud Therapeutics and currently in Phase III for Osteoarthritis Pain. According to GlobalData, Phase...